Shah, N. J., Bupathi, M., McKay, R. R., Garmezy, B., Picus, J., Ornstein, M. C., Figlin, R. A., Lam, E. T., Gelmann, E. P., Hammers, H. J., Rank, B. H., Zhao, S., Barata, P. C., Salkeni, M. A., Shao, Y. F., Tykodi, S. S., Hutson, T. E., Chisamore, M. J., Iglesias, J. L., Motzer, R. J. (2025). A phase 1b, open-label, safety, tolerability, and efficacy study of HC-7366 in combination with belzutifan in patients with advanced or metastatic renal cell carcinoma (NCT06234605).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps4614